FDA Approves Zydelig To Treat Three Types Of Blood Cancer

(HNGN) – The U.S. Food and Drug Administration today approved Zydelig, a drug to treat patients with three types of blood cancers. Zydelig can be used to treat patients whose chronic lymphocytic leukemia (CLL) has relapsed. Additionally, the drug can also be used in combination Read More